Literature DB >> 33197009

A Mouse Femoral Ostectomy Model to Assess Bone Graft Substitutes.

Ryan P Trombetta1, Emma K Knapp2, Hani A Awad3,4.   

Abstract

The shortcomings of autografts and allografts in bone defect healing have prompted researchers to develop suitable alternatives. Numerous biomaterials have been developed as bone graft substitutes each with their own advantages and disadvantages. However, in order to test if these biomaterials provide an adequate replacement of the clinical standard, a clinically representative animal model is needed to test their efficacy. In this chapter, we describe a mouse model that establishes a critical sized defect in the mid-diaphysis of the femur to evaluate the performance of bone graft substitutes. This is achieved by performing a femoral ostectomy and stabilization utilizing a femoral plate and titanium screws. The resulting defect enables the bone regenerative potential of bone graft substitutes to be investigated. Lastly, we provide instruction on assessing the torsional strength of the healed femurs to quantitatively evaluate the degree of healing as a primary outcome measure.

Entities:  

Keywords:  Biomechanics; Bone; Bone graft substitute; Critical sized defect; Healing; Mouse model; Scaffold; Torsional testing

Mesh:

Substances:

Year:  2021        PMID: 33197009      PMCID: PMC8299532          DOI: 10.1007/978-1-0716-1028-2_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  30 in total

1.  Effects of altered crystalline structure and increased initial compressive strength of calcium sulfate bone graft substitute pellets on new bone formation.

Authors:  Robert M Urban; Thomas M Turner; Deborah J Hall; Susan I Infanger; Naveed Cheema; Tae-Hong Lim; Jon Moseley; Michael Carroll; Michael Roark
Journal:  Orthopedics       Date:  2004-01       Impact factor: 1.390

2.  Platelet-rich plasma: evidence to support its use.

Authors:  Earl G Freymiller
Journal:  J Oral Maxillofac Surg       Date:  2004-08       Impact factor: 1.895

3.  Platelet-rich plasma: Growth factor enhancement for bone grafts.

Authors:  R E Marx; E R Carlson; R M Eichstaedt; S R Schimmele; J E Strauss; K R Georgeff
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1998-06

4.  Effects of mechanical factors on the fracture healing process.

Authors:  L E Claes; C A Heigele; C Neidlinger-Wilke; D Kaspar; W Seidl; K J Margevicius; P Augat
Journal:  Clin Orthop Relat Res       Date:  1998-10       Impact factor: 4.176

Review 5.  Bone tissue engineering: recent advances and challenges.

Authors:  Ami R Amini; Cato T Laurencin; Syam P Nukavarapu
Journal:  Crit Rev Biomed Eng       Date:  2012

6.  Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis.

Authors:  Uwe Joosten; Alexander Joist; G Gosheger; Ulf Liljenqvist; Burkhard Brandt; Christof von Eiff
Journal:  Biomaterials       Date:  2005-09       Impact factor: 12.479

Review 7.  Size Matters: Defining Critical in Bone Defect Size!

Authors:  Emil H Schemitsch
Journal:  J Orthop Trauma       Date:  2017-10       Impact factor: 2.512

8.  A prospective randomized controlled trial of a bioresorbable calcium phosphate paste (alpha-BSM) in treatment of displaced intra-articular calcaneal fractures.

Authors:  Herman S Johal; Richard E Buckley; Ian L D Le; Ross K Leighton
Journal:  J Trauma       Date:  2009-10

9.  Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover.

Authors:  John Street; Min Bao; Leo deGuzman; Stuart Bunting; Franklin V Peale; Napoleone Ferrara; Hope Steinmetz; John Hoeffel; Jeffrey L Cleland; Ann Daugherty; Nicholas van Bruggen; H Paul Redmond; Richard A D Carano; Ellen H Filvaroff
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-12       Impact factor: 11.205

10.  Allografts about the Knee in Young Patients with High-Grade Sarcoma.

Authors:  Brian E Brigman; Francis J Hornicek; Mark C Gebhardt; Henry J Mankin
Journal:  Clin Orthop Relat Res       Date:  2004-04       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.